Definitive Contract HHSN268201400079C
Award Date 9/25/14
Potential Completion Date 3/24/15
Potential Value $647K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $672,660 firm fixed-price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of an Illumina HiSeq DNA sequencer. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided sequencing systems and related goods and services to support research and diagnostic applications across...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a $75,050 firm fixed price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a "HiSeq 2000 Silver Service Contract". The contract provides for sequencing services and maintenance support for Illumina's HiSeq 2000 genetic sequencing system, which is used to support life science research and molecular diagnostics at NHLBI. This award is not associated with a set-aside...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
- This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing services. The contract has a ceiling value of $95,569.54 and does not include any set-aside provisions. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously received prime federal contracts and grants from agencies including the NIH, Centers...
- This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the procurement of Illumina kits and reagents to support next-generation sequencing activities at the NHLBI Sequencing Core Facility. The contract has a ceiling value of $25,696.80 and a period of performance...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Illumina, Inc. for sequencing kits to support the Illumina HiSeq 2500 gene sequencing platform. The total award ceiling is $19,450.92, with an ultimate completion date of April 24, 2015. Illumina is a for-profit manufacturer of genetic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and...
- This is a firm fixed price service contract awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $411,137.00, provides for the renewal and maintenance of an Illumina HiSeq2500 sequencing system. The contract has no set-aside designation and was awarded on June 7, 2017, with a completion date of December 10,...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract provides for a HISEQ 2500 Silver Support Plan, with an ultimate completion date of April 28, 2022, and a ceiling value of $96,921.00. Illumina has previously held prime federal contracts and sub-grants with various civilian agencies to supply sequencing instruments, reagents, and...